Acute Modification of Hemodynamic Forces in Patients with Severe Aortic Stenosis after Transcatheter Aortic Valve Implantation.
Alessandro VairoLorenzo ZaccaroAndrea BallatoreLorenzo AiraleFabrizio D'AscenzoGianluca AlunniFederico ConrottoLuca ScudelerDaniela MascarettiDavide MiccoliMichele La TorreMauro RinaldiGianni PedrizzettiStefano SalizzoniGaetano Maria De FerrariPublished in: Journal of clinical medicine (2023)
Transcatheter aortic valve implantation (TAVI) is the established first-line treatment for patient with severe aortic stenosis not suitable for surgery. Echocardiographic evaluation of hemodynamic forces (HDFs) is a growing field, holding the potential to early predict improvement in LV function. A prospective observational study was conducted. Transthoracic echocardiography was performed before and after TAVI. HDFs were analyzed along with traditional left ventricular (LV) function parameters. Twenty-five consecutive patients undergoing TAVI were enrolled: mean age 83 ± 5 years, 74.5% male, mean LV Ejection Fraction (LVEF) at baseline 57 ± 8%. Post-TAVI echocardiographic evaluation was performed 2.4 ± 1.06 days after the procedure. HDF amplitude parameters improved significantly after the procedure: LV Longitudinal Forces (LF) apex-base [mean difference (MD) 1.79%; 95% CI 1.07-2.5; p -value < 0.001]; LV systolic LF apex-base (MD 2.6%; 95% CI 1.57-3.7; p -value < 0.001); LV impulse (LVim) apex-base (MD 2.9%; 95% CI 1.48-4.3; p -value < 0.001). Similarly, HDFs orientation parameters improved: LVLF angle (MD 1.5°; 95% CI 0.07-2.9; p -value = 0.041); LVim angle (MD 2.16°; 95% CI 0.76-3.56; p -value = 0.004). Conversely, global longitudinal strain and LVEF did not show any significant difference before and after the procedure. Echocardiographic analysis of HDFs could help differentiate patients with LV function recovery after TAVI from patients with persistent hemodynamic dysfunction.
Keyphrases
- aortic stenosis
- transcatheter aortic valve implantation
- left ventricular
- ejection fraction
- aortic valve replacement
- transcatheter aortic valve replacement
- minimally invasive
- molecular dynamics
- left atrial
- hypertrophic cardiomyopathy
- aortic valve
- heart failure
- acute myocardial infarction
- cardiac resynchronization therapy
- patients undergoing
- mitral valve
- liver failure
- early onset
- computed tomography
- high resolution
- pulmonary hypertension
- drug induced
- risk assessment
- coronary artery disease
- cross sectional
- climate change
- extracorporeal membrane oxygenation
- respiratory failure
- human health
- acute coronary syndrome
- clinical evaluation